NHI causes uncertainty with its ambitious goals in South Africa. Analyse the challenges to health financing reforms and public funding.
You must be a subscriber to access all of this content.
Adcock Ingram's Urizone receives legal protection as the court halts Cipla's Furizome, citing trademark infringement.
You must be a subscriber to access all of this content.
Pharma giants push EU to revise drug pricing policies, seeking higher prices to bolster investment and innovation in Europe.
You must be a subscriber to access all of this content.
Explore the Aspen Pharmacare manufacturing dispute and its potential impact on core earnings for the 2025 financial year.
You must be a subscriber to access all of this content.
Health Minister Aaron Motsoaledi discusses the NHI advertising campaign designed to address misinformation and support health efforts.
You must be a subscriber to access all of this content.